Page last updated: 2024-08-17

1,2-dipalmitoylphosphatidylcholine and Pneumocystis Infections

1,2-dipalmitoylphosphatidylcholine has been researched along with Pneumocystis Infections in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Beers, MF; Lipschik, GY; Moore, SD; Treml, JF1
Benfield, TL; Dichter, JR; Jensen, BN; Lawrence, M; Lundgren, JD; Nielsen, TL; Schattenkerk, J; Shelhamer, J1

Trials

1 trial(s) available for 1,2-dipalmitoylphosphatidylcholine and Pneumocystis Infections

ArticleYear
Pneumocystis carinii pneumonia in HIV-infected patients: effect of steroid therapy on surfactant level.
    Respiratory medicine, 1999, Volume: 93, Issue:6

    Topics: 1,2-Dipalmitoylphosphatidylcholine; Adult; AIDS-Related Opportunistic Infections; Bronchoalveolar Lavage Fluid; Chemotherapy, Adjuvant; Female; Glucocorticoids; Humans; Male; Methylprednisolone; Middle Aged; Pneumocystis Infections

1999

Other Studies

1 other study(ies) available for 1,2-dipalmitoylphosphatidylcholine and Pneumocystis Infections

ArticleYear
Pneumocystis carinii glycoprotein A inhibits surfactant phospholipid secretion by rat alveolar type II cells.
    The Journal of infectious diseases, 1998, Volume: 177, Issue:1

    Topics: 1,2-Dipalmitoylphosphatidylcholine; Adenosine Triphosphate; Animals; Antibodies, Blocking; Cells, Cultured; Endotoxins; Fungal Proteins; Lipids; Male; Membrane Glycoproteins; Pneumocystis; Pneumocystis Infections; Pulmonary Alveoli; Rats; Rats, Sprague-Dawley; Recombinant Proteins

1998